Viking Therapeutics (NASDAQ:VKTX) Trading Down 4.9% After Analyst Downgrade
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) shares traded down 4.9% on Monday after Maxim Group lowered their price target on the stock from $120.00 to $70.00. Maxim Group currently has a buy rating on the stock. Viking Therapeutics traded as low as $31.00 and last traded at $30.97. 886,719 shares traded hands during […]
![Viking Therapeutics (NASDAQ:VKTX) Trading Down 4.9% After Analyst Downgrade](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/viking-therapeutics-inc-logo-1200x675.png?v=20240306130605&w=240&h=240&zc=2)